Here, we explore the integration of artificial intelligence and machine learning into the complex field of cell and gene therapy manufacturing. We highlight the Insights™ platform, which harmonizes diverse data streams to create predictive models that enhance production efficiency and product quality, and demonstrate how deep learning can non-destructively evaluate stem cell pluripotency using early-stage microscopy and process data.